Publications by authors named "Barbara J Ring"

Claim this Profile
L
Low-Turnover Drug Molecules: A Current Challenge for Drug Metabolism Scientists.
J Matthew Hutzler, Barbara J Ring, Shelby R Anderson

Drug Metab Dispos· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenomics of gemcitabine metabolism: functional analysis of genetic variants in cytidine deaminase and deoxycytidine kinase.
Jessica A Roseberry Baker, Enaksha R Wickremsinhe, Claire H Li, Olukayode A Oluyedun, Anne H Dantzig, Barbara J Ring

Drug Metab Dispos· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: comparative assessment of prediction methods of human volume of distribution.
Rhys Do Jones, Hannah M Jones, Malcolm Rowland, Christopher R Gibson, James W T Yates, Barbara J Ring

J Pharm Sci· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: prediction of plasma concentration-time profiles in human from in vivo preclinical data by using the Wajima approach.
Ragini Vuppugalla, Punit Marathe, Handan He, Rhys D O Jones, James W T Yates, Barbara J Ring

J Pharm Sci· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 1: goals, properties of the PhRMA dataset, and comparison with literature datasets.
Patrick Poulin, Hannah M Jones, Rhys Do Jones, James W T Yates, Christopher R Gibson, Barbara J Ring

J Pharm Sci· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: prediction of plasma concentration-time profiles in human by using the physiologically-based pharmacokinetic modeling approach.
Patrick Poulin, Rhys D O Jones, Hannah M Jones, Christopher R Gibson, Malcolm Rowland, Barbara J Ring

J Pharm Sci· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance.
Barbara J Ring, Jenny Y Chien, Kimberly K Adkison, Hannah M Jones, Malcolm Rowland

J Pharm Sci· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disposition and metabolism of semagacestat, a {gamma}-secretase inhibitor, in humans.
Ping Yi, Chad Hadden, Palaniappan Kulanthaivel, Nathan Calvert, William Annes, Barbara J Ring

Drug Metab Dispos· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interactions of two major metabolites of prasugrel, a thienopyridine antiplatelet agent, with the cytochromes P450.
Jessica L Fayer Rehmel, James A Eckstein, Nagy A Farid, John B Heim, Steve C Kasper, Barbara J Ring

Drug Metab Dispos· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictions of the in vivo clearance of drugs from rate of loss using human liver microsomes for phase I and phase II biotransformations.
Michael A Mohutsky, Jenny Y Chien, Barbara J Ring, Steven A Wrighton

Pharm Res· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical pharmacokinetics of atomoxetine.
John-Michael Sauer, Barbara J Ring, Jennifer W Witcher

Clin Pharmacokinet· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of tadalafil on cytochrome P450 3A4-mediated clearance: studies in vitro and in vivo.
Barbara J Ring, Beverley E Patterson, Malcolm I Mitchell, Mark Vandenbranden, Jennifer Gillespie

Clin Pharmacol Ther· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of incubation conditions on the enzyme kinetics of udp-glucuronosyltransferases.
Matthew G Soars, Barbara J Ring, Steven A Wrighton

Drug Metab Dispos· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes.
J Andrew Williams, Barbara J Ring, Varon E Cantrell, Kristina Campanale, David R Jones

Drug Metab Dispos· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The interactions of a selective protein kinase C beta inhibitor with the human cytochromes P450.
Barbara J Ring, Jennifer S Gillespie, Shelly N Binkley, Kristina M Campanale, Steven A Wrighton

Drug Metab Dispos· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7.
J Andrew Williams, Barbara J Ring, Varon E Cantrell, David R Jones, James Eckstein

Drug Metab Dispos· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of the human cytochromes P450 responsible for atomoxetine metabolism.
Barbara J Ring, Jennifer S Gillespie, James A Eckstein, Steven A Wrighton

Drug Metab Dispos· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis